Cannabis’ active components show promise in halting the progression of certain neurodegerative disorders and should be evaluated in clinical trials, according to a review published online in theBritish Journal of Pharmacology.
An international team of researchers from Spain and Israel assessed the potential of cannabinoids to moderate Huntington’s disease (HD) and Parkinson’s disease (PD), two degenerative brain disorders that are mostly unresponsive to conventional treatment therapies.
“Cannabinoids are promising medicines to slow down disease progression in neurodegenerative disorders including Parkinson’s disease (PD) and Huntington’s disease (HD), two of the most important disorders affecting the basal ganglia,” authors reported.
Read complete article here:
http://www.theweedblog.com/marijuana-compounds-offer-promising-treatment-option-for-neurodegenerative-disorders/